Document Detail

Obstruction alters the effect of prostaglandin E2 on ureteral contractility.
MedLine Citation:
PMID:  15798415     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: Although our understanding of ureteral physiology during acute obstruction remains limited, we believe that prostanoids (prostaglandins [PGs], thromboxanes, prostacyclins) play a major role in modulation of ureteral contractility and that inhibition of prostanoid synthesis causes substantial reduction in in-vitro and in-vivo ureteral contractility rates. The purpose of this study was to determine the in-vitro effects of PGE2 on chronically obstructed human and acutely obstructed porcine ureters. MATERIALS AND METHODS: Female pigs underwent unilateral laparoscopic ureteral obstruction. Following 1, 2, 6, 24, and 48 hours of obstruction (n = 3 at all points), animals were euthanized, and obstructed, contralateral nonobstructed, and normal (from unobstructed pigs) ureters were harvested. Chronically obstructed human ureter was obtained from subjects who underwent nephrectomy to remove nonfunctioning kidneys. Normal human ureter was obtained from the discarded portion of excess distal ureter in patients undergoing elective donor nephrectomy. Rings 4 to 5 mm long were suspended in aerated Krebs buffer, and their spontaneous contractions and contraction in response to various concentrations of PGE2 were recorded. RESULTS: Prostaglandin E2 increased contractility in chronically obstructed human ureters. In acutely obstructed porcine ureteral segments, low concentrations of PGE2 inhibited ureteral contractility in a dose-dependent fashion, similar to controls. At higher concentrations of PGE2, contractility was increased. This increase was more pronounced with longer intervals of obstruction in a time-dependent manner. CONCLUSION: Prostaglandin E2 increased contractility in obstructed ureters while relaxing normal and nonobstructed ureters. The response to PGE2 was accentuated by a longer duration of obstruction. Prostaglandin E2 may be a unique target for pharmacologic modulation in the treatment of symptoms associated with acute urinary obstruction.
Patrick S Lowry; Travis J Jerde; Dale E Bjorling; Jennifer L Maskel; Stephen Y Nakada
Related Documents :
18067925 - Attenuation of inos in an lps-stimulated macrophage model by omega-3 fatty acids is ind...
6425865 - Modification of prostaglandin generation by l-histidine--possible pathogenetic implicat...
371855 - Prostaglandins and renin release: the effect of pgi2, pge2, and 13,14-dihydro pge2 on t...
3040855 - A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta...
10844115 - An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of induci...
21682825 - Platelets significantly modify procoagulant activities in haemophilia a.
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Journal of endourology / Endourological Society     Volume:  19     ISSN:  0892-7790     ISO Abbreviation:  J. Endourol.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-30     Completed Date:  2005-05-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8807503     Medline TA:  J Endourol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  183-7     Citation Subset:  IM    
Department of Surgery, Division of Urology, University of Wisconsin Medical School, Madison, Wisconsin 53792-3236, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dinoprostone / pharmacology*
Muscle Contraction / drug effects*,  physiology
Muscle, Smooth / drug effects*,  physiopathology
Ureteral Obstruction / physiopathology*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genetic and dietary factors in urinary citrate excretion.
Next Document:  Three-dimensional CT virtual endoscopy in the detection of simulated tumors in a novel phantom bladd...